litlas
ログインアカウント作成

Kevan C. Herold

1983–2025 年に発表

別表記
Kevan C Herold
156
論文数
28,477
被引用数
91
h 指数
148
i10 指数

被引用数

Kevan C. Herold の年別被引用数1984 年: 被引用 2 件1985 年: 被引用 4 件1986 年: 被引用 6 件1987 年: 被引用 4 件1988 年: 被引用 11 件1989 年: 被引用 1 件1990 年: 被引用 7 件1991 年: 被引用 7 件1992 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 4 件1995 年: 被引用 16 件1996 年: 被引用 26 件1997 年: 被引用 28 件1998 年: 被引用 33 件1999 年: 被引用 40 件2000 年: 被引用 37 件2001 年: 被引用 27 件2002 年: 被引用 40 件2003 年: 被引用 40 件2004 年: 被引用 59 件2005 年: 被引用 68 件2006 年: 被引用 85 件2007 年: 被引用 105 件2008 年: 被引用 139 件2009 年: 被引用 162 件2010 年: 被引用 146 件2011 年: 被引用 134 件2012 年: 被引用 208 件2013 年: 被引用 270 件2014 年: 被引用 186 件2015 年: 被引用 241 件2016 年: 被引用 230 件2017 年: 被引用 244 件2018 年: 被引用 268 件2019 年: 被引用 856 件2020 年: 被引用 991 件2021 年: 被引用 1,195 件2022 年: 被引用 977 件2023 年: 被引用 898 件2024 年: 被引用 1,398 件2025 年: 被引用 815 件2026 年: 被引用 15 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,136 件、この内訳の 30.3%中国: 引用元論文 829 件、この内訳の 8%イギリス: 引用元論文 768 件、この内訳の 7.4%ドイツ: 引用元論文 631 件、この内訳の 6.1%イタリア: 引用元論文 455 件、この内訳の 4.4%カナダ: 引用元論文 400 件、この内訳の 3.9%オーストラリア: 引用元論文 339 件、この内訳の 3.3%フランス: 引用元論文 329 件、この内訳の 3.2%日本: 引用元論文 253 件、この内訳の 2.5%スウェーデン: 引用元論文 247 件、この内訳の 2.4%オランダ: 引用元論文 231 件、この内訳の 2.2%ベルギー: 引用元論文 217 件、この内訳の 2.1%
0%30.3%その他 24.2%

機関

分野

  • Medicine44.6%
  • Biochemistry, Genetics and Molecular Biology34.4%
  • Immunology and Microbiology16.1%
  • Neuroscience1.3%
  • Nursing1.1%
  • Engineering0.6%
  • その他1.9%

トピック

  • Diabetes and associated disorders10.6%
  • Pancreatic function and diabetes8.7%
  • Diabetes Management and Research6.4%
  • Immune Cell Function and Interaction6.2%
  • T-cell and B-cell Immunology5.8%
  • CAR-T cell therapy research3.3%
  • その他59%

共著者

全論文

検索で開く
  1. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    著者: Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum - New England Journal of Medicine 2019 被引用: 1,112

  2. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

    著者: Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler - Diabetes Care 2015 被引用: 1,148

  3. Type 1 diabetes immunotherapy using polyclonal regulatory T cells

    著者: Jeffrey A. Bluestone, Jane H. Buckner, Mark Fitch, Stephen E. Gitelman, Shipra Gupta, Marc K. Hellerstein, Kevan C. Herold, Angela Lares, Michael R. F. Lee, Kelvin Li, Weihong Liu, S. Alice Long, Lisa M. Masiello, Vinh Nguyen, Amy Putnam, Mary Rieck, Peter H. Sayre, Qizhi Tang - Science Translational Medicine 2015 被引用: 1,013

  4. Reprogramming human T cell function and specificity with non-viral genome targeting

    著者: Theodore L. Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P. Jonathan Li, Joseph Hiatt, Justin D. Saco, Paige Krystofinski, Han Li, Victoria Tobin, David N. Nguyen, Michael R. Lee, Amy Putnam, Andrea L. Ferris, Jeff W. Chen, Jean-Nicolas Schickel, Laurence Pellerin, David Carmody, Gorka Alkorta‐Aranburu, Daniela del Gaudio, Hiroyuki Matsumoto, Montse Morell, Ying Mao, Min Cho, Rolen M. Quadros, Channabasavaiah B. Gurumurthy, Baz Smith, Michael Haugwitz, Stephen H. Hughes, Jonathan S. Weissman, Kathrin Schumann, Jonathan H. Esensten, Andrew P. May, Alan Ashworth, Gary M. Kupfer, Siri Atma W. Greeley, Rosa Bacchetta, Eric Meffre, Maria Grazia Roncarolo, Neil Romberg, Kevan C. Herold, Antoni Ribas, Manuel D. Leonetti, Alexander Marson - Nature 2018 被引用: 871

  5. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

    著者: Emily K. Sims, Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long, Susan Geyer, Antoinette Moran, Carla J. Greenbaum, Carmella Evans‐Molina, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group, Linda A. DiMeglio, Stephen E. Gitelman, Peter A. Gottlieb, Jennifer B. Marks, Wayne D. Moore, Henry Rodriguez, William E. Russell, Desmond Schatz, Eva Tsalikian, Diane K. Wherrett, Anette‐Gabriele Ziegler - Science Translational Medicine 2021 被引用: 359

  6. Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

    著者: Eleanor L. Ramos, Colin Dayan, Lucienne Chatenoud, Zdenĕk Šumnı́k, Kimber M. Simmons, Agnieszka Szypowska, Stephen E. Gitelman, Laura A. Knecht, Elisabeth Niemoeller, Wei Tian, Kevan C. Herold - New England Journal of Medicine 2023 被引用: 234

  7. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

    著者: Emily K. Sims, Rachel Besser, Colin Dayan, Cristy Geno Rasmussen, Carla J. Greenbaum, Kurt Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank B. Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette‐Gabriele Ziegler, Kevan C. Herold, for the NIDDK Type 1 Diabetes TrialNet Study Group - Diabetes 2022 被引用: 230

  8. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

    著者: Shen Dong, Kamir J. Hiam-Galvez, Cody T. Mowery, Kevan C. Herold, Stephen E. Gitelman, Jonathan H. Esensten, Weihong Liu, Angela Lares, Ashley Leinbach, Michael Lee, Vinh Nguyen, Stanley Tamaki, Whitney Tamaki, Courtney Tamaki, Morvarid Mehdizadeh, Amy Putnam, Matthew H. Spitzer, Chun Ye, Qizhi Tang, Jeffrey A. Bluestone - JCI Insight 2021 被引用: 221

  9. Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

    著者: Angeliki M. Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, Pamela Clark, Harriet M. Kluger, Sarah A. Weiss, Scott Gettinger, Mario Sznol, Arabella Young, Robert J Rushakoff, James Lee, Jeffrey A. Bluestone, Mark S. Anderson, Kevan C. Herold - Diabetes 2018 被引用: 575

  10. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

    著者: Manuela Battaglia, Simi Ahmed, Mark S. Anderson, Mark A. Atkinson, Dorothy Becker, Polly J. Bingley, Emanuele Bosi, Todd M. Brusko, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, Kevan C. Herold, Martin J. Hessner, Mikael Knip, Laura M. Jacobsen, Jeffrey P. Krischer, S. Alice Long, Markus Lundgren, Eoin McKinney, Noel G. Morgan, Richard A. Oram, Tomi Pastinen, Michael C. Peters, Alessandra Petrelli, Xiaoning Qian, María J. Redondo, Bart O. Roep, Desmond Schatz, David Skibinski, Mark Peakman - Diabetes Care 2019 被引用: 344

  11. The immunology of type 1 diabetes

    著者: Kevan C. Herold, Thomas Delong, Ana Luisa Perdigoto, Noah Biru, Todd M. Brusko, Lucy S. K. Walker - Nature reviews. Immunology 2024 被引用: 190

  12. Immunotherapy: Building a bridge to a cure for type 1 diabetes

    著者: Jeffrey A. Bluestone, Jane H. Buckner, Kevan C. Herold - Science 2021 被引用: 214

  13. Genetics, pathogenesis and clinical interventions in type 1 diabetes

    著者: Jeffrey A. Bluestone, Kevan C. Herold, George S. Eisenbarth - Nature 2010 被引用: 1,266

  14. Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial

    著者: Kevan C. Herold, Stephen E. Gitelman, Mario R. Ehlers, Peter A. Gottlieb, Carla J. Greenbaum, William Hagopian, Karen D. Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard, Peter H. Sayre, James McNamara, Jeffrey A. Bluestone, and the AbATE Study Team - Diabetes 2013 被引用: 405

  15. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

    著者: William E. Russell, Brian N. Bundy, Mark S. Anderson, Laura A. Cooney, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Michael J. Haller, Jeffrey P. Krischer, Ingrid Libman, Peter S. Linsley, S. Alice Long, Sandra Lord, Daniel J. Moore, Wayne V. Moore, Antoinette Moran, Andrew Muir, Philip Raskin, Jay S. Skyler, John M. Wentworth, Diane K. Wherrett, Darrell M. Wilson, Anette‐Gabriele Ziegler, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group - Diabetes Care 2023 被引用: 96

  16. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

    著者: Kevan C. Herold, Stephen E. Gitelman, Peter A. Gottlieb, Laura A. Knecht, Ralph Raymond, Eleanor L. Ramos - Diabetes Care 2023 被引用: 123

  17. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

    著者: Nicole Sherry, William Hagopian, Johnny Ludvigsson, Sunil Kumar, Jack Wahlen, Robert J. Ferry, Bruce W. Bode, Stephen Aronoff, Christopher M. Holland, David A Carlin, Karen L. King, Ronald L. Wilder, Stanley R. Pillemer, Ezio Bonvini, Syd Johnson, Kathryn E. Stein, Scott Koenig, Kevan C. Herold, Anastasia G. Daifotis - The Lancet 2011 被引用: 489

  18. Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes

    著者: S. Alice Long, Jerill Thorpe, Hannah A. DeBerg, Vivian H. Gersuk, James A. Eddy, Kristina M. Harris, Mario R. Ehlers, Kevan C. Herold, Gerald T. Nepom, Peter S. Linsley - Science Immunology 2016 被引用: 249

  19. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    著者: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco ほか 212 名 - Diabetes Care 2018 被引用: 180

  20. Control of TH17 cells occurs in the small intestine

    著者: Enric Esplugues, Samuel Huber, Nicola Gagliani, Anja E. Hauser, Terrence Town, Yisong Y. Wan, William O’Connor, Anthony Rongvaux, Nico van Rooijen, Ann M. Haberman, Yoichiro Iwakura, Vijay K. Kuchroo, Jay K. Kolls, Jeffrey A. Bluestone, Kevan C. Herold, Richard A. Flavell - Nature 2011 被引用: 661

  21. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

    著者: Antoinette Moran, Brian N. Bundy, Dorothy Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, Srinath Sanda, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, Linda Pickersgill, Eelco J.P. de Koning, Anette‐G. Ziegler, Bernhard O. Boehm, Klaus Badenhoop, Nanette C. Schloot, J. F. Bak, Paolo Pozzilli, Dı́dac Mauricio, Marc Y. Donath, Luís Castaño, Ana M. Wägner, H. H. Lervang, Hans Perrild, Thomas Mandrup‐Poulsen - The Lancet 2013 被引用: 354

  22. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells

    著者: Amanda Hernandez, Alexandra Kitz, Chuan Wu, Daniel E. Lowther, Donald M. Rodriguez, Nalini Vudattu, Songyan Deng, Kevan C. Herold, Vijay K. Kuchroo, Markus Kleinewietfeld, David A. Hafler - Journal of Clinical Investigation 2015 被引用: 332

  23. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    著者: María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson ほか 1,520 名 - Diabetes Care 2018 被引用: 169

  24. Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

    著者: Kevan C. Herold, William Hagopian, Julie Auger, Ena Poumian-Ruiz, Lesley Taylor, David Donaldson, Stephen E. Gitelman, David M. Harlan, Danlin Xu, Robert A. Zivin, Jeffrey A. Bluestone - New England Journal of Medicine 2002 被引用: 1,215